Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Chen, S. Y. Lin, C. Y. Chi, H. Weng, S. L. Li, S. T. Tai, Y. L. Huang, Y. N. Huang, H. Lin, C. H. Chiu, N. C.

The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Marra, A. R. Kobayashi, T. Callado, G. Y. Pardo, I. Gutfreund, M. C. Hsieh, M. K. Lin, V. Alsuhaibani, M. Hasegawa, S. Tholany, J. Perencevich, E. N. Salinas, J. L. Edmond, M. B. Rizzo, L. V.

The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Khazanov, G. K. Stewart, R. Pieri, M. F. Huang, C. Robertson, C. T. Schaefer, K. A. Ko, H. Fishman, J.

The effectiveness of financial incentives for COVID-19 vaccination: A systematic review

  • All age groups
  • COVID-19
  • Acceptance
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Flanagan, P. Dowling, M. Sezgin, D. Mereckiene, J. Murphy, L. Giltenane, M. Carr, P. Gethin, G.

The effectiveness of interventions to improve the seasonal influenza vaccination uptake among nurses: A systematic review

  • Healthcare workers
  • Influenza
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Huang, Y. Huang, X. Yu, R.

The effectiveness of nonfinancial interventions and monetary incentives on COVID-19 vaccination: A meta-analysis

  • All age groups
  • COVID-19
  • Acceptance
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Xu, J. Lan, X. Zhang, L. Zhang, X. Zhang, J. Song, M. Liu, J.

The effectiveness of the first dose COVID-19 booster vs. full vaccination to prevent SARS-CoV-2 infection and severe COVID-19 clinical event: a meta-analysis and systematic review of longitudinal studies

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Al-Haideri, M. T. Mannani, R. Kaboli, R. Gharebakhshi, F. Darvishzadehdeldari, S. Tahmasebi, S. Faramarzi, F. Cotrina-Aliaga, J. C. Khorasani, S. Alimohammadi, M. Darvishi, M. Akhavan-Sigari, R.

The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Soheili, M. Khateri, S. Moradpour, F. Mohammadzedeh, P. Zareie, M. Mortazavi, S. M. M. Manifar, S. Kohan, H. G. Moradi, Y.

The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ponduri, A. Azmy, M. C. Axler, E. Lin, J. Schwartz, R. Chiril Dikkers, F. G. Yang, C. J. Mehta, V. Gangar, M.

The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Yang, X. H. Bao, W. J. Zhang, H. Fu, S. K. Jin, H. M.

The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...